Skip to main content
GMDA logo

Gamida Cell Ltd. (GMDA) Stock Analysis

DELISTED

What happened to Gamida Cell Ltd. (GMDA) stock?

Gamida Cell Ltd. (GMDA) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
MCap: $4.34M| Vol: 19.05M| 52-wk range: $0.0327 – $0.0395

Market cap $4.34M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Gamida Cell Ltd. (GMDA). Gamida Cell Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative cell therapies for blood cancers and serious hematologic diseases.

Last analyzed: Jun 14, 2026
Gamida Cell Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative cell therapies for blood cancers and serious hematologic diseases. Its lead product candidate, omidubicel, has completed Phase III trials for high-risk hematologic malignancies and is also in earlier-stage trials for severe aplastic anemia.

Gamida Cell Ltd. (GMDA) Healthcare & Pipeline Overview

Employees143
Model self-rating on this text: 68% (not a measure of the evidence) Updated: Jun 14, 2026

More about this archive record

Can I still buy GMDA shares?

No. GMDA stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for GMDA elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before GMDA stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Gamida Cell Ltd.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.